Viridian Therapeutics, Inc..
VRDN.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Viridian Therapeutics, Inc. is a biotechnology company focused on discovering and developing novel therapies for patients suffering from serious diseases but is primarily focused on thyroid eye disease (TED). The company's pipeline includes multiple clinical-stage product candidates, including VRDN-...Show More
Better Health for All
20
Viridian Therapeutics is entirely focused on developing therapies for serious and rare diseases, including Thyroid Eye Disease (TED) and autoimmune diseases.
1
Their product candidates, such as Veligrotug, have demonstrated statistically significant clinical benefits in Phase 3 trials, received Breakthrough Therapy Designation, and are under Priority Review by the FDA, indicating a high potential for revolutionary health benefits.
2
The company conducts global Phase 3 clinical trials (THRIVE, THRIVE-2, REVEAL-1, REVEAL-2) for its candidates, with enrollment exceeding targets due to strong patient demand, and adheres to ethical standards for clinical research, including respecting participants and ensuring full transparency of results.
3
Veligrotug was generally well-tolerated in Phase 3 clinical trials, with no specific adverse event rates provided, but the general well-tolerated status suggests a low adverse event rate.
4
The company focuses on people living with serious and rare diseases, and considers Expanded Access for patients with serious or immediately life-threatening conditions when no alternative therapies are available.
5
The company provides articles and information about Thyroid Eye Disease, its history, science, and patient journey.
6
The company prohibits illegal drugs or alcohol on premises, except for pre-approved events, and expects employees to avoid excessive consumption at such events.
7
Fair Money & Economic Opportunity
0
No evidence available to assess Viridian Therapeutics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
60
The company's CEO to median employee pay ratio was 3:1 in fiscal year 2024.
1
For health insurance, the company provides medical, dental, and vision insurance, a company-sponsored Health Reimbursement Account, and a Healthcare FSA.
2
Historically, the organization covered 100% of employee insurance premiums, though this benefit structure changed in 2026.
3
All 143 employees as of December 31, 2024, are full-time, with zero part-time employees.
4
Employee ratings on Glassdoor show an average of 3.6 out of 5 stars, with 59% recommending to a friend and 63% having a positive business outlook.
5
There are growing concerns about retention due to changes in the total rewards structure and the elimination of previously available perks, which has diminished overall employee morale.
6
Leadership communication is perceived as confrontational, and executive feedback is often discouraging.
7
Fair Trade & Ethical Sourcing
0
No specific, concrete data points were found in the provided articles to assess Viridian Therapeutics, Inc. against the 'Fair Trade & Ethical Sourcing' value. The articles primarily discuss corporate governance, financial audit committee functions, and a general code of business conduct for employees, rather than specific supply chain ethical sourcing practices, supplier audits, or related metrics.
Honest & Fair Business
-40
Viridian Therapeutics has a formal Whistleblower Policy, a dedicated hotline, and allows for anonymous reporting, with a stated commitment to non-retaliation.
1
However, there is no explicit evidence of independent investigation processes for whistleblower reports. The company also has a separate Anti-Bribery Corruption Policy, and a Senior Director, Compliance role is responsible for monitoring activities to ensure adherence to relevant laws, regulations, and company policies, including fraud and abuse and anti-kickback statutes.
2
While an FCPA-compliant policy is implied by the role's responsibilities, the frequency and effectiveness metrics of related training are not specified.
Kind to Animals
0
No evidence available to assess Viridian Therapeutics, Inc. on Kind to Animals.
No War, No Weapons
0
No evidence available to assess Viridian Therapeutics, Inc. on No War, No Weapons.
Planet-Friendly Business
-20
Viridian Therapeutics, Inc. has no specific regulatory actions, violations, fines, or compliance issues mentioned.
1
Respect for Cultures & Communities
0
No evidence available to assess Viridian Therapeutics, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess Viridian Therapeutics, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
-40
Viridian Therapeutics reported a 22% reduction in water consumption and a 17.5 metric ton reduction in laboratory waste in 2023.
1
The company has set targets to reduce water consumption by 30% by 2025 and laboratory waste to 15 metric tons by 2025.
2
For hazardous waste, Viridian Therapeutics achieved a 98.3% hazardous chemical neutralization rate in 2023.
3